Cargando…
Assessing clinical investigators’ perceptions of relevance and competency of clinical trials skills: An international AIDS Malignancy Consortium (AMC) study
INTRODUCTION: The AIDS Malignancy Consortium (AMC) conducts clinical trials of therapeutic and prevention strategies for cancer in people living with HIV. With its recent expansion to Sub-Saharan Africa and Latin America, there was a need to increase the competence of clinical investigators (CIs) to...
Autores principales: | Lee, Jeannette Y., Lensing, Shelly V, Botello-Harbaum, Maria T., Medina, Rebecca, Zozus, Meredith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057474/ https://www.ncbi.nlm.nih.gov/pubmed/33948251 http://dx.doi.org/10.1017/cts.2020.520 |
Ejemplares similares
-
The AIDS malignancy clinical trials consortium (AMC) patient navigator (PN) initiative
por: Botello-Harbaum, Maria T, et al.
Publicado: (2012) -
Phase II AIDS Malignancy Consortium (AMC) trial of imatinib in AIDS-associated Kaposi’s sarcoma (KS)
por: Koon, Henry B, et al.
Publicado: (2010) -
Safety and Tolerability of Carboplatin and Paclitaxel in Cancer Patients with HIV (AMC-078), an AIDS Malignancy Consortium (AMC) Study
por: Haigentz, Missak, et al.
Publicado: (2022) -
Phase II AIDS Malignancy Consortium (AMC) trial of topical halofuginone in AIDS-associated Kaposi’s sarcoma (KS): clinical and biological effects using a novel intra-patient control design
por: Krown, Susan E, et al.
Publicado: (2010) -
Pooled analysis of AIDS Malignancy Consortium (AMC) trials evaluating rituximab plus either CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin’s lymphoma
por: Barta, Stefan K, et al.
Publicado: (2010)